A Target‐Mediated Drug Disposition Model to Explain Nonlinear Pharmacokinetics of the 11β‐Hydroxysteroid Dehydrogenase Type 1 Inhibitor SPI‐62 in Healthy Adults

SPI‐62 is a selective and potent small‐molecule inhibitor of 11β‐hydroxysteroid dehydrogenase type 1 (HSD‐1). SPI‐62 has demonstrated substantial and complex nonlinear pharmacokinetics (PK) in humans that is characterized by unusually low plasma exposure at low doses, dose‐dependent volume of distri...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Nan, Katz, David A., An, Guohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Pharmacometrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596879/
https://www.ncbi.nlm.nih.gov/pubmed/34110620
http://dx.doi.org/10.1002/jcph.1925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596879/
https://www.ncbi.nlm.nih.gov/pubmed/34110620
http://dx.doi.org/10.1002/jcph.1925

Ejemplares similares